Federal health regulators have rejected an application filed by Acadia Pharmaceuticals to expand the use of its blockbuster antipsychotic drug, Nuplazid, highlighting concerns that the medication may not be effective among certain subgroups of dementia patients.…
A new study reveals that Fosamax and similar osteoporosis drugs failed to provide any benefits in preventing hip fractures after seven years of use.…
Thorazine and similar psychotropic drugs significantly increase the risk of tardive dyskinesia among the mentally ill, according to the findings of a new study.…
The FDA has approved the use of a drug combination of Opdivo and Yervoy as a first-line treatment for mesothelioma.…
A new study reveals that many so-called “brain boosting” dietary supplements contain unapproved drugs and other label inaccuracies.…
A new study warns that Fosamax and similar drugs greatly increase the risk of atypical femur fractures after more than five years of use.…
A compounded heparin sodium recall announced by the FDA warns that certain lots may contain preservatives which could put newborn lives at risk.…
A new study finds that women are more likely to suffer drug side effects and be overmedicated due to the lack of women test subjects in clinical trials.…
AbbVie has agreed to pay $24 million to California to resolve claims it deployed “nurse ambassadors” who used deception and gifts to get doctors to prescribe Humira and who interfered with doctor-patient communications.…
The FDA is proposing a new rule which requires manufacturers of investigational drugs to report every year on how patients taking those unapproved drugs are faring.…
